Shareholding for the Period Ended September 30, 2018
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here07-10-2018
07-10-2018
Compliance Certificate For The Half Year Ended On September 30, 2018.
Pursuant to regulation 7(3) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the certificate for the half year ended on September 30, 2018.06-10-2018
Compliance Under Regulation 40(10) Of The SEBI (LODR) Regulations, 2015.
Pursuant to Regulation 40(10)of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the certificate, received from a Company Secretary in Practice as required under Regulation 40(9) of said Regulations, for the half year ended September 30, 2018.05-10-2018
Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 012120 Name of the Signatory :- ANKITA JAINDesignation :- Company Secretary and Compliance Officer04-10-2018
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Nectar Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here29-09-2018
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of Annual General Meeting (AGM) and Scrutinizer''s Report are attached. All resolutions were passed with requisite majority, including the resolution of declaration of Final Dividend @ Re. 0.05/- per equity share (5% on the face value of Re. 1/- per equity share) for the financial year 2017-18. The Dividend will be paid latest by October 27, 2018.29-09-2018
Summary Of The Proceedings At The 23RD Annual General Meeting Of Nectar Lifesciences Limited
Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith proceedings of Annual General Meeting held on September 28, 2018.28-09-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith newspaper publication under the provisions of Section 91 of the Companies Act, 2013 and Rule 20 of Companies (Management and Administration) Rules, 2014, in respect of Notice of Annual General Meeting, book closure and E-voting instructions, which have been published in the following newspapers: 1. Business Standard (English-all editions) dated 30.08.2018-circulating in the whole or substantially the whole of India....30-08-2018
Notice Of Annual General Meeting, Annual Report And Remote E-Voting Instructions.
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of the Annual Report for the financial year ended on 31.03.2018 (containing notice of 23rd Annual General Meeting, Standalone financial statements, Directors' and Auditors' Reports thereon and Corporate Governance Report, Management Discussion and Analysis Report and consolidated...23-08-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
please find enclosed the copies of Financial Results of the Company for the period ended on June 30, 2018, which have been published in the following newspapers: 1. Business Standard (English-all editions) dated 08.08.2018- circulating in the whole or substantially the whole of India. 2. Desh Sewak (Punjabi) dated 08.08.2018 being published in language of the region where the registered office of the Company is situated.08-08-2018